| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f39b1e3d9344927b0de347c92c02d90f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf8373f3013dca535a8f1ad5458725f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_498764d2c727924d5bc0cfc84b1d0654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1566deb10301f0ec237b69cfba9baed4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2009-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c718f48287764ebf6aff9f111ed0b6eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eef652525ed3ef07d90d3b2745c37527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b250a728e2a74501cd1803c326a1673a |
| publicationDate |
2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010086070-A1 |
| titleOfInvention |
Methods of treating bone disorders |
| abstract |
The invention relates to the use of a DBC1 inhibitor for the manufacture of a medicament for the treatment and/or prevention of a bone disorder such as osteoporosis. The invention further relates to a method for identifying putative therapeutic agents that may be useful for the treatment of osteoporosis, comprising: (a) providing a candidate compound; (b) assaying for the ability of the candidate compound to inhibit (i) expression of the DBC1 gene in a cell, or (ii) the binding of the DBC1 protein to the osteocalcin promoter. |
| priorityDate |
2009-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |